FDA warns retailers after ByHeart infant formula recall tied to botulism outbreak investigation
The FDA said inspections found recalled ByHeart infant formula still on store shelves weeks after the company’s voluntary recall, following an outbreak investigation into infant botulism linked to the product. The agency said it has sent warning letters and emphasized that supply-chain partners must act quickly when products pose serious risks to infants.
Recall enforcement tightened after formula remained for sale
The U.S. Food and Drug Administration said it is taking steps to improve recall effectiveness after investigators repeatedly found recalled ByHeart infant formula still being offered to consumers following the manufacturer’s voluntary recall. FDA officials said this was discovered during thousands of retail checks conducted with state and local partners.
According to the agency, recalled product was found on shelves for more than three weeks in at least one case and across a large number of locations in many states. The FDA said it has issued warning letters and stressed that retailers play a critical role in preventing dangerous products from remaining available.
Outbreak investigation context: infant botulism
The FDA’s action follows an outbreak investigation into infant botulism linked to ByHeart Whole Nutrition infant formula. Because infants are especially vulnerable, the FDA framed the situation as a high-stakes test of recall execution across the supply chain.
The agency emphasized that when a recall is issued, responsibility extends beyond the manufacturer. Distributors, stores, and other partners must quickly pull affected products and verify that they are not being sold in person or online.
What consumers can do right now
- Check your home for any ByHeart infant formula products that may be covered by the recall.
- Do not feed recalled formula to infants; follow recall instructions for disposal or returns.
- If your infant has symptoms that worry you, contact a pediatrician or seek urgent care, especially for signs consistent with botulism (such as weakness or feeding difficulty).
Why recall compliance matters
Infant nutrition products are widely distributed and frequently purchased in routine shopping trips, which means even a small number of missed removals can expose families to serious health risk. The FDA said its enforcement push is intended to strengthen accountability and reduce the chance that recalled goods linger in the marketplace.